Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 24, 2009
Hepatitis C virus kinetics during the first phase of pegylated interferon-alpha-2b with ribavirin therapy in patients with living donor liver transplantationTatsuki Ichikawa, Kazuhiko Nakao, Hisamitsu Miyaaki, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2006
The impact of newer treatment modalities on survival in patients with hepatocellular carcinomaNaota Taura, Keisuke Hamasaki, Kazuhiko Nakao, et al.Experimental and Therapeutic Medicine|February 14, 2018
Current characteristics of hemophilia patients co-infected with HIV/HCV in JapanSatoshi Miuma, Masaaki Hidaka, Mitsuhisa Takatsuki, et al.International Journal of Oncology|June 26, 2008
Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesisTakashi Goto, Hiroki Ishikawa, Kojiro Matsumoto, et al.International Journal of Oncology|July 26, 2006
DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cellsDaisuke Nishimura, Hiroki Ishikawa, Kojiro Matsumoto, et al.Journal of Cellular Biochemistry|May 15, 2012
Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cellsSatoshi Miuma, Tatsuki Ichikawa, Kazuhiko Arima, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 29, 2008
Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cellsKumi Hirano, Tatsuki Ichikawa, Kazuhiko Nakao, et al.Nutrition Research (New York, N.Y.)|March 17, 2009
A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinomaShigeyuki Takeshita, Tatsuki Ichikawa, Kazuhiko Nakao, et al.Journal of Gastroenterology|May 14, 2009
Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathwayAzusa Matsumoto, Tatsuki Ichikawa, Kazuhiko Nakao, et al.The American Journal of Gastroenterology|October 10, 2006
Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patientsNaota Taura, Tatsuki Ichikawa, Keisuke Hamasaki, et al.Pageof 6